Maja Relja
Maja Relja
dr. sc., dr. med., profesor neurologije
Potvrđena adresa e-pošte na
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease
A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ...
European Journal of Neurology 20 (1), 16-34, 2013
Safety and efficacy of botulinum toxin type A following long‐term use
M Naumann, A Albanese, F Heinen, G Molenaers, M Relja
European Journal of Neurology 13, 35-40, 2006
Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study
N Klepac, V Trkulja, M Relja, T Babić
European Journal of Neurology 15 (2), 128-133, 2008
A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic …
M Relja, AC Poole, J Schoenen, J Pascual, X Lei, C Thompson
Cephalalgia 27 (6), 492-503, 2007
Effect of Long‐Lasting Diabetes Mellitus on Rat and Human Brain Monoamines
Z Lacković, M Šalković, Z Kuci, M Relja
Journal of neurochemistry 54 (1), 143-147, 1990
Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects
N Klepac, M Relja, R Klepac, S Hećimović, T Babić, V Trkulja
Journal of neurology 254 (12), 1676-1683, 2007
Treatment of tension type headache by local injection of botulinum toxin
M Relja
European journal of neurology 4 (2), S71-S73, 1997
Botulinum toxin type A in experimental neuropathic pain
L Bach-Rojecky, M Relja, Z Lacković
Journal of neural transmission 112 (2), 215-219, 2005
Botulinum toxin in tension-type headache
M Relja, S Telarović
Journal of neurology 251 (1), i12-i14, 2004
Evidence for a widely distributed peripheral dopaminergic system.
Z Lacković, M Relja
Federation proceedings 42 (13), 3000-3004, 1983
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
A Albanese, G Abbruzzese, D Dressler, W Duzynski, S Khatkova, MJ Marti, ...
Journal of neurology 262 (10), 2201-2213, 2015
Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross‐sectional study in Croatia
N Klepac, S Pikija, T Kraljić, M Relja, V Trkulja, S Juren, I Pavliček, ...
European Journal of Neurology 14 (2), 194-198, 2007
Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission?
Z Lacković, M Relja, NH Neff
Journal of Neurochemistry 38 (5), 1453-1458, 1982
Treatment of tension-type headache with botulinum toxin: 1-year follow-up
M Relja
Headache World 2000, 2000
Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
MF Contarino, J Van Den Dool, Y Balash, K Bhatia, N Giladi, JH Koelman, ...
Frontiers in neurology 8, 35, 2017
Treatment of Tension-Type Headache by Injection of Botulinum toxin Type A: Double-blind placebo-Controlled Study
M Relja, M Koršić
American Academy of Neurology 51st Annual Meeting, 1999
A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
M Relja, N Klepac
Journal of the neurological sciences 248 (1-2), 251-254, 2006
The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study
M Jakovljevic, N Pivac, A Mihaljevic-Peles, M Mustapic, M Relja, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2), 399-402, 2007
Restless legs syndrome in hemodialysis patients: association with calcium antagonists
S Telarović, M Relja, V Trkulja
European Neurology 58 (3), 166-169, 2007
Botulinum toxin type A as prophylactic treatment in chronic tension type headache: long-term follow-up study
MA Relja, N Klepac
Neurology 56 (8), A349-A350, 2001
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20